nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP2C8—Dapsone—systemic lupus erythematosus	0.0656	0.146	CbGbCtD
Trametinib—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0569	0.127	CbGbCtD
Trametinib—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0456	0.102	CbGbCtD
Trametinib—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0431	0.0962	CbGbCtD
Trametinib—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0304	0.0679	CbGbCtD
Trametinib—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.0284	0.0634	CbGbCtD
Trametinib—CYP3A4—Dapsone—systemic lupus erythematosus	0.0266	0.0594	CbGbCtD
Trametinib—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0231	0.0515	CbGbCtD
Trametinib—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0231	0.0515	CbGbCtD
Trametinib—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0198	0.0442	CbGbCtD
Trametinib—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0195	0.0436	CbGbCtD
Trametinib—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0185	0.0413	CbGbCtD
Trametinib—CYP3A4—Prednisone—systemic lupus erythematosus	0.0184	0.0412	CbGbCtD
Trametinib—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0175	0.039	CbGbCtD
Trametinib—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0115	0.0257	CbGbCtD
Trametinib—MAP2K2—blood plasma—systemic lupus erythematosus	0.00743	0.107	CbGeAlD
Trametinib—MAP2K1—connective tissue—systemic lupus erythematosus	0.00449	0.0646	CbGeAlD
Trametinib—MAP2K1—skin of body—systemic lupus erythematosus	0.00406	0.0584	CbGeAlD
Trametinib—MAP2K1—kidney—systemic lupus erythematosus	0.00383	0.055	CbGeAlD
Trametinib—MAP2K2—skin of body—systemic lupus erythematosus	0.00357	0.0514	CbGeAlD
Trametinib—MAP2K2—kidney—systemic lupus erythematosus	0.00337	0.0484	CbGeAlD
Trametinib—CYP3A4—urine—systemic lupus erythematosus	0.00334	0.048	CbGeAlD
Trametinib—MAP2K1—lymphoid tissue—systemic lupus erythematosus	0.00329	0.0473	CbGeAlD
Trametinib—MAP2K2—cortex of kidney—systemic lupus erythematosus	0.00328	0.0472	CbGeAlD
Trametinib—MAP2K1—bone marrow—systemic lupus erythematosus	0.00299	0.043	CbGeAlD
Trametinib—MAP2K2—lymphoid tissue—systemic lupus erythematosus	0.00289	0.0416	CbGeAlD
Trametinib—MAP2K2—tendon—systemic lupus erythematosus	0.00272	0.0391	CbGeAlD
Trametinib—MAP2K1—lung—systemic lupus erythematosus	0.00271	0.039	CbGeAlD
Trametinib—MAP2K2—bone marrow—systemic lupus erythematosus	0.00263	0.0379	CbGeAlD
Trametinib—CYP2C8—blood plasma—systemic lupus erythematosus	0.00257	0.037	CbGeAlD
Trametinib—MAP2K1—nervous system—systemic lupus erythematosus	0.00251	0.0361	CbGeAlD
Trametinib—MAP2K1—central nervous system—systemic lupus erythematosus	0.00242	0.0348	CbGeAlD
Trametinib—MAP2K2—lung—systemic lupus erythematosus	0.00239	0.0343	CbGeAlD
Trametinib—MAP2K2—nervous system—systemic lupus erythematosus	0.00221	0.0318	CbGeAlD
Trametinib—MAP2K2—central nervous system—systemic lupus erythematosus	0.00213	0.0306	CbGeAlD
Trametinib—CYP3A4—blood plasma—systemic lupus erythematosus	0.00174	0.0251	CbGeAlD
Trametinib—CYP2C8—kidney—systemic lupus erythematosus	0.00117	0.0168	CbGeAlD
Trametinib—CYP3A4—kidney—systemic lupus erythematosus	0.00079	0.0114	CbGeAlD
Trametinib—CYP3A4—nervous system—systemic lupus erythematosus	0.000518	0.00745	CbGeAlD
Trametinib—CYP3A4—central nervous system—systemic lupus erythematosus	0.000499	0.00718	CbGeAlD
Trametinib—Oedema—Prednisolone—systemic lupus erythematosus	0.000192	0.000882	CcSEcCtD
Trametinib—Neutropenia—Methotrexate—systemic lupus erythematosus	0.000192	0.00088	CcSEcCtD
Trametinib—Dizziness—Azathioprine—systemic lupus erythematosus	0.000191	0.000879	CcSEcCtD
Trametinib—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000191	0.000876	CcSEcCtD
Trametinib—Cough—Triamcinolone—systemic lupus erythematosus	0.000189	0.000867	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000187	0.000861	CcSEcCtD
Trametinib—Oedema—Hydrocortisone—systemic lupus erythematosus	0.000187	0.000861	CcSEcCtD
Trametinib—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000187	0.000859	CcSEcCtD
Trametinib—Hypertension—Triamcinolone—systemic lupus erythematosus	0.000187	0.000858	CcSEcCtD
Trametinib—Hypertension—Methylprednisolone—systemic lupus erythematosus	0.000186	0.000856	CcSEcCtD
Trametinib—Infection—Hydrocortisone—systemic lupus erythematosus	0.000186	0.000855	CcSEcCtD
Trametinib—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000186	0.000855	CcSEcCtD
Trametinib—Hyperhidrosis—Prednisolone—systemic lupus erythematosus	0.000186	0.000852	CcSEcCtD
Trametinib—Myalgia—Triamcinolone—systemic lupus erythematosus	0.000184	0.000846	CcSEcCtD
Trametinib—Vomiting—Azathioprine—systemic lupus erythematosus	0.000184	0.000845	CcSEcCtD
Trametinib—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000184	0.000844	CcSEcCtD
Trametinib—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.000184	0.000844	CcSEcCtD
Trametinib—Myalgia—Methylprednisolone—systemic lupus erythematosus	0.000184	0.000844	CcSEcCtD
Trametinib—Eye disorder—Prednisone—systemic lupus erythematosus	0.000183	0.000843	CcSEcCtD
Trametinib—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000183	0.000842	CcSEcCtD
Trametinib—Infestation NOS—Methotrexate—systemic lupus erythematosus	0.000183	0.000839	CcSEcCtD
Trametinib—Infestation—Methotrexate—systemic lupus erythematosus	0.000183	0.000839	CcSEcCtD
Trametinib—Rash—Azathioprine—systemic lupus erythematosus	0.000182	0.000838	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000182	0.000838	CcSEcCtD
Trametinib—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000182	0.000837	CcSEcCtD
Trametinib—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000182	0.000836	CcSEcCtD
Trametinib—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000182	0.000836	CcSEcCtD
Trametinib—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000182	0.000835	CcSEcCtD
Trametinib—Headache—Azathioprine—systemic lupus erythematosus	0.000181	0.000833	CcSEcCtD
Trametinib—Hyperhidrosis—Hydrocortisone—systemic lupus erythematosus	0.000181	0.000832	CcSEcCtD
Trametinib—Dizziness—Leflunomide—systemic lupus erythematosus	0.000181	0.00083	CcSEcCtD
Trametinib—Constipation—Cyclosporine—systemic lupus erythematosus	0.00018	0.000828	CcSEcCtD
Trametinib—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.00018	0.000827	CcSEcCtD
Trametinib—Renal failure—Methotrexate—systemic lupus erythematosus	0.00018	0.000825	CcSEcCtD
Trametinib—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000179	0.000821	CcSEcCtD
Trametinib—Stomatitis—Methotrexate—systemic lupus erythematosus	0.000178	0.000818	CcSEcCtD
Trametinib—Angiopathy—Prednisone—systemic lupus erythematosus	0.000178	0.000818	CcSEcCtD
Trametinib—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000178	0.000816	CcSEcCtD
Trametinib—Oedema—Triamcinolone—systemic lupus erythematosus	0.000177	0.000811	CcSEcCtD
Trametinib—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000176	0.000808	CcSEcCtD
Trametinib—Arrhythmia—Prednisone—systemic lupus erythematosus	0.000175	0.000805	CcSEcCtD
Trametinib—Infection—Triamcinolone—systemic lupus erythematosus	0.000175	0.000805	CcSEcCtD
Trametinib—Infection—Methylprednisolone—systemic lupus erythematosus	0.000175	0.000804	CcSEcCtD
Trametinib—Haematuria—Methotrexate—systemic lupus erythematosus	0.000174	0.0008	CcSEcCtD
Trametinib—Vomiting—Leflunomide—systemic lupus erythematosus	0.000174	0.000798	CcSEcCtD
Trametinib—Insomnia—Prednisolone—systemic lupus erythematosus	0.000174	0.000797	CcSEcCtD
Trametinib—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000173	0.000793	CcSEcCtD
Trametinib—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000173	0.000792	CcSEcCtD
Trametinib—Epistaxis—Methotrexate—systemic lupus erythematosus	0.000172	0.000792	CcSEcCtD
Trametinib—Rash—Leflunomide—systemic lupus erythematosus	0.000172	0.000791	CcSEcCtD
Trametinib—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000172	0.000791	CcSEcCtD
Trametinib—Mental disorder—Prednisone—systemic lupus erythematosus	0.000172	0.00079	CcSEcCtD
Trametinib—Nausea—Azathioprine—systemic lupus erythematosus	0.000172	0.00079	CcSEcCtD
Trametinib—Headache—Leflunomide—systemic lupus erythematosus	0.000171	0.000786	CcSEcCtD
Trametinib—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000171	0.000786	CcSEcCtD
Trametinib—Erythema—Prednisone—systemic lupus erythematosus	0.000171	0.000785	CcSEcCtD
Trametinib—Malnutrition—Prednisone—systemic lupus erythematosus	0.000171	0.000785	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000171	0.000784	CcSEcCtD
Trametinib—Hyperhidrosis—Triamcinolone—systemic lupus erythematosus	0.000171	0.000784	CcSEcCtD
Trametinib—Hyperhidrosis—Methylprednisolone—systemic lupus erythematosus	0.00017	0.000782	CcSEcCtD
Trametinib—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.00017	0.000779	CcSEcCtD
Trametinib—Hypertension—Betamethasone—systemic lupus erythematosus	0.000169	0.000778	CcSEcCtD
Trametinib—Hypertension—Dexamethasone—systemic lupus erythematosus	0.000169	0.000778	CcSEcCtD
Trametinib—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000168	0.000773	CcSEcCtD
Trametinib—Myalgia—Betamethasone—systemic lupus erythematosus	0.000167	0.000767	CcSEcCtD
Trametinib—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000167	0.000767	CcSEcCtD
Trametinib—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000167	0.000766	CcSEcCtD
Trametinib—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000167	0.000766	CcSEcCtD
Trametinib—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000165	0.000757	CcSEcCtD
Trametinib—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000164	0.000754	CcSEcCtD
Trametinib—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000163	0.000748	CcSEcCtD
Trametinib—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000163	0.000747	CcSEcCtD
Trametinib—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000163	0.000747	CcSEcCtD
Trametinib—Nausea—Leflunomide—systemic lupus erythematosus	0.000162	0.000746	CcSEcCtD
Trametinib—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000162	0.000744	CcSEcCtD
Trametinib—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000162	0.000743	CcSEcCtD
Trametinib—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000162	0.000742	CcSEcCtD
Trametinib—Vision blurred—Prednisone—systemic lupus erythematosus	0.000161	0.00074	CcSEcCtD
Trametinib—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000161	0.000739	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000161	0.000739	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.00016	0.000737	CcSEcCtD
Trametinib—Oedema—Betamethasone—systemic lupus erythematosus	0.00016	0.000736	CcSEcCtD
Trametinib—Oedema—Dexamethasone—systemic lupus erythematosus	0.00016	0.000736	CcSEcCtD
Trametinib—Insomnia—Triamcinolone—systemic lupus erythematosus	0.00016	0.000733	CcSEcCtD
Trametinib—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000159	0.000732	CcSEcCtD
Trametinib—Infection—Betamethasone—systemic lupus erythematosus	0.000159	0.000731	CcSEcCtD
Trametinib—Infection—Dexamethasone—systemic lupus erythematosus	0.000159	0.000731	CcSEcCtD
Trametinib—Anaemia—Prednisone—systemic lupus erythematosus	0.000158	0.000725	CcSEcCtD
Trametinib—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000157	0.000721	CcSEcCtD
Trametinib—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000157	0.000721	CcSEcCtD
Trametinib—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000157	0.00072	CcSEcCtD
Trametinib—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000157	0.00072	CcSEcCtD
Trametinib—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000155	0.000711	CcSEcCtD
Trametinib—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000155	0.000711	CcSEcCtD
Trametinib—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000153	0.000704	CcSEcCtD
Trametinib—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000153	0.000704	CcSEcCtD
Trametinib—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000152	0.000699	CcSEcCtD
Trametinib—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000152	0.000699	CcSEcCtD
Trametinib—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000152	0.000697	CcSEcCtD
Trametinib—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000151	0.000695	CcSEcCtD
Trametinib—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000149	0.000685	CcSEcCtD
Trametinib—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000149	0.000684	CcSEcCtD
Trametinib—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000148	0.000681	CcSEcCtD
Trametinib—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000148	0.000681	CcSEcCtD
Trametinib—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000148	0.000679	CcSEcCtD
Trametinib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000148	0.000678	CcSEcCtD
Trametinib—Hypertension—Prednisone—systemic lupus erythematosus	0.000148	0.000678	CcSEcCtD
Trametinib—Chills—Methotrexate—systemic lupus erythematosus	0.000147	0.000676	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000146	0.00067	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000146	0.00067	CcSEcCtD
Trametinib—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000146	0.000669	CcSEcCtD
Trametinib—Myalgia—Prednisone—systemic lupus erythematosus	0.000146	0.000668	CcSEcCtD
Trametinib—Arthralgia—Prednisone—systemic lupus erythematosus	0.000146	0.000668	CcSEcCtD
Trametinib—Insomnia—Betamethasone—systemic lupus erythematosus	0.000145	0.000665	CcSEcCtD
Trametinib—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000145	0.000665	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000145	0.000664	CcSEcCtD
Trametinib—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000144	0.000663	CcSEcCtD
Trametinib—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000144	0.000661	CcSEcCtD
Trametinib—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000144	0.00066	CcSEcCtD
Trametinib—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000143	0.000656	CcSEcCtD
Trametinib—Erythema—Methotrexate—systemic lupus erythematosus	0.000143	0.000656	CcSEcCtD
Trametinib—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000141	0.000647	CcSEcCtD
Trametinib—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.00014	0.000642	CcSEcCtD
Trametinib—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.00014	0.000641	CcSEcCtD
Trametinib—Dizziness—Cyclosporine—systemic lupus erythematosus	0.00014	0.000641	CcSEcCtD
Trametinib—Oedema—Prednisone—systemic lupus erythematosus	0.000139	0.000641	CcSEcCtD
Trametinib—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000139	0.000639	CcSEcCtD
Trametinib—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000139	0.000639	CcSEcCtD
Trametinib—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000139	0.000639	CcSEcCtD
Trametinib—Infection—Prednisone—systemic lupus erythematosus	0.000139	0.000636	CcSEcCtD
Trametinib—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000138	0.000635	CcSEcCtD
Trametinib—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000138	0.000635	CcSEcCtD
Trametinib—Back pain—Methotrexate—systemic lupus erythematosus	0.000138	0.000634	CcSEcCtD
Trametinib—Fatigue—Betamethasone—systemic lupus erythematosus	0.000138	0.000634	CcSEcCtD
Trametinib—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000138	0.000634	CcSEcCtD
Trametinib—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000137	0.000628	CcSEcCtD
Trametinib—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000136	0.000625	CcSEcCtD
Trametinib—Skin disorder—Prednisone—systemic lupus erythematosus	0.000135	0.000622	CcSEcCtD
Trametinib—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000135	0.000619	CcSEcCtD
Trametinib—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000135	0.000618	CcSEcCtD
Trametinib—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000135	0.000618	CcSEcCtD
Trametinib—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000134	0.000616	CcSEcCtD
Trametinib—Rash—Cyclosporine—systemic lupus erythematosus	0.000133	0.000611	CcSEcCtD
Trametinib—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000133	0.00061	CcSEcCtD
Trametinib—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000133	0.000609	CcSEcCtD
Trametinib—Headache—Cyclosporine—systemic lupus erythematosus	0.000132	0.000607	CcSEcCtD
Trametinib—Anaemia—Methotrexate—systemic lupus erythematosus	0.000132	0.000606	CcSEcCtD
Trametinib—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000131	0.000601	CcSEcCtD
Trametinib—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000131	0.000601	CcSEcCtD
Trametinib—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000131	0.000601	CcSEcCtD
Trametinib—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.00013	0.000596	CcSEcCtD
Trametinib—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00013	0.000595	CcSEcCtD
Trametinib—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000129	0.000592	CcSEcCtD
Trametinib—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000128	0.000589	CcSEcCtD
Trametinib—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000128	0.000587	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000127	0.000584	CcSEcCtD
Trametinib—Dizziness—Prednisolone—systemic lupus erythematosus	0.000127	0.000583	CcSEcCtD
Trametinib—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000127	0.000582	CcSEcCtD
Trametinib—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000127	0.000581	CcSEcCtD
Trametinib—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000127	0.000581	CcSEcCtD
Trametinib—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000127	0.000581	CcSEcCtD
Trametinib—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000127	0.000581	CcSEcCtD
Trametinib—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000126	0.00058	CcSEcCtD
Trametinib—Insomnia—Prednisone—systemic lupus erythematosus	0.000126	0.000579	CcSEcCtD
Trametinib—Nausea—Cyclosporine—systemic lupus erythematosus	0.000125	0.000575	CcSEcCtD
Trametinib—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000125	0.000574	CcSEcCtD
Trametinib—Cough—Methotrexate—systemic lupus erythematosus	0.000125	0.000572	CcSEcCtD
Trametinib—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000125	0.000572	CcSEcCtD
Trametinib—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000124	0.000569	CcSEcCtD
Trametinib—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000122	0.000561	CcSEcCtD
Trametinib—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000122	0.000558	CcSEcCtD
Trametinib—Myalgia—Methotrexate—systemic lupus erythematosus	0.000122	0.000558	CcSEcCtD
Trametinib—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000121	0.000557	CcSEcCtD
Trametinib—Rash—Prednisolone—systemic lupus erythematosus	0.000121	0.000556	CcSEcCtD
Trametinib—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000121	0.000555	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000121	0.000555	CcSEcCtD
Trametinib—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000121	0.000553	CcSEcCtD
Trametinib—Fatigue—Prednisone—systemic lupus erythematosus	0.00012	0.000552	CcSEcCtD
Trametinib—Headache—Prednisolone—systemic lupus erythematosus	0.00012	0.000552	CcSEcCtD
Trametinib—Constipation—Prednisone—systemic lupus erythematosus	0.000119	0.000548	CcSEcCtD
Trametinib—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000119	0.000547	CcSEcCtD
Trametinib—Rash—Hydrocortisone—systemic lupus erythematosus	0.000118	0.000543	CcSEcCtD
Trametinib—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000118	0.000542	CcSEcCtD
Trametinib—Headache—Hydrocortisone—systemic lupus erythematosus	0.000117	0.000539	CcSEcCtD
Trametinib—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000117	0.000536	CcSEcCtD
Trametinib—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000116	0.000535	CcSEcCtD
Trametinib—Infection—Methotrexate—systemic lupus erythematosus	0.000116	0.000532	CcSEcCtD
Trametinib—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000115	0.000528	CcSEcCtD
Trametinib—Asthenia—Betamethasone—systemic lupus erythematosus	0.000115	0.000528	CcSEcCtD
Trametinib—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000114	0.000525	CcSEcCtD
Trametinib—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000114	0.000524	CcSEcCtD
Trametinib—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000114	0.000524	CcSEcCtD
Trametinib—Nausea—Prednisolone—systemic lupus erythematosus	0.000114	0.000524	CcSEcCtD
Trametinib—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000113	0.00052	CcSEcCtD
Trametinib—Pruritus—Betamethasone—systemic lupus erythematosus	0.000113	0.00052	CcSEcCtD
Trametinib—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000113	0.00052	CcSEcCtD
Trametinib—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000113	0.000518	CcSEcCtD
Trametinib—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000112	0.000515	CcSEcCtD
Trametinib—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000112	0.000514	CcSEcCtD
Trametinib—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000111	0.000511	CcSEcCtD
Trametinib—Rash—Triamcinolone—systemic lupus erythematosus	0.000111	0.000511	CcSEcCtD
Trametinib—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000111	0.000511	CcSEcCtD
Trametinib—Rash—Methylprednisolone—systemic lupus erythematosus	0.000111	0.00051	CcSEcCtD
Trametinib—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000111	0.00051	CcSEcCtD
Trametinib—Headache—Triamcinolone—systemic lupus erythematosus	0.000111	0.000508	CcSEcCtD
Trametinib—Headache—Methylprednisolone—systemic lupus erythematosus	0.00011	0.000507	CcSEcCtD
Trametinib—Abdominal pain—Prednisone—systemic lupus erythematosus	0.00011	0.000506	CcSEcCtD
Trametinib—Body temperature increased—Prednisone—systemic lupus erythematosus	0.00011	0.000506	CcSEcCtD
Trametinib—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.00011	0.000503	CcSEcCtD
Trametinib—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.00011	0.000503	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000106	0.000488	CcSEcCtD
Trametinib—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000106	0.000486	CcSEcCtD
Trametinib—Dizziness—Betamethasone—systemic lupus erythematosus	0.000106	0.000486	CcSEcCtD
Trametinib—Insomnia—Methotrexate—systemic lupus erythematosus	0.000105	0.000484	CcSEcCtD
Trametinib—Nausea—Triamcinolone—systemic lupus erythematosus	0.000105	0.000482	CcSEcCtD
Trametinib—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000105	0.00048	CcSEcCtD
Trametinib—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000102	0.000468	CcSEcCtD
Trametinib—Vomiting—Betamethasone—systemic lupus erythematosus	0.000102	0.000468	CcSEcCtD
Trametinib—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000101	0.000465	CcSEcCtD
Trametinib—Rash—Dexamethasone—systemic lupus erythematosus	0.000101	0.000464	CcSEcCtD
Trametinib—Rash—Betamethasone—systemic lupus erythematosus	0.000101	0.000464	CcSEcCtD
Trametinib—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000101	0.000463	CcSEcCtD
Trametinib—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000101	0.000463	CcSEcCtD
Trametinib—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000101	0.000462	CcSEcCtD
Trametinib—Fatigue—Methotrexate—systemic lupus erythematosus	0.000101	0.000462	CcSEcCtD
Trametinib—Headache—Betamethasone—systemic lupus erythematosus	0.0001	0.000461	CcSEcCtD
Trametinib—Headache—Dexamethasone—systemic lupus erythematosus	0.0001	0.000461	CcSEcCtD
Trametinib—Asthenia—Prednisone—systemic lupus erythematosus	0.0001	0.00046	CcSEcCtD
Trametinib—Pruritus—Prednisone—systemic lupus erythematosus	9.87e-05	0.000453	CcSEcCtD
Trametinib—Diarrhoea—Prednisone—systemic lupus erythematosus	9.54e-05	0.000438	CcSEcCtD
Trametinib—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	9.53e-05	0.000438	CcSEcCtD
Trametinib—Nausea—Betamethasone—systemic lupus erythematosus	9.51e-05	0.000437	CcSEcCtD
Trametinib—Nausea—Dexamethasone—systemic lupus erythematosus	9.51e-05	0.000437	CcSEcCtD
Trametinib—Dizziness—Prednisone—systemic lupus erythematosus	9.22e-05	0.000424	CcSEcCtD
Trametinib—Abdominal pain—Methotrexate—systemic lupus erythematosus	9.22e-05	0.000423	CcSEcCtD
Trametinib—Body temperature increased—Methotrexate—systemic lupus erythematosus	9.22e-05	0.000423	CcSEcCtD
Trametinib—Vomiting—Prednisone—systemic lupus erythematosus	8.87e-05	0.000407	CcSEcCtD
Trametinib—Rash—Prednisone—systemic lupus erythematosus	8.8e-05	0.000404	CcSEcCtD
Trametinib—Dermatitis—Prednisone—systemic lupus erythematosus	8.79e-05	0.000404	CcSEcCtD
Trametinib—Headache—Prednisone—systemic lupus erythematosus	8.74e-05	0.000401	CcSEcCtD
Trametinib—Asthenia—Methotrexate—systemic lupus erythematosus	8.36e-05	0.000384	CcSEcCtD
Trametinib—Nausea—Prednisone—systemic lupus erythematosus	8.29e-05	0.00038	CcSEcCtD
Trametinib—Pruritus—Methotrexate—systemic lupus erythematosus	8.25e-05	0.000379	CcSEcCtD
Trametinib—Diarrhoea—Methotrexate—systemic lupus erythematosus	7.98e-05	0.000366	CcSEcCtD
Trametinib—Dizziness—Methotrexate—systemic lupus erythematosus	7.71e-05	0.000354	CcSEcCtD
Trametinib—Vomiting—Methotrexate—systemic lupus erythematosus	7.41e-05	0.00034	CcSEcCtD
Trametinib—Rash—Methotrexate—systemic lupus erythematosus	7.35e-05	0.000338	CcSEcCtD
Trametinib—Dermatitis—Methotrexate—systemic lupus erythematosus	7.34e-05	0.000337	CcSEcCtD
Trametinib—Headache—Methotrexate—systemic lupus erythematosus	7.3e-05	0.000335	CcSEcCtD
Trametinib—Nausea—Methotrexate—systemic lupus erythematosus	6.92e-05	0.000318	CcSEcCtD
Trametinib—MAP2K1—Signaling by ERBB4—IL6—systemic lupus erythematosus	4.18e-05	0.000158	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NCF2—systemic lupus erythematosus	4.15e-05	0.000157	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—C3—systemic lupus erythematosus	4.13e-05	0.000156	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PTPRC—systemic lupus erythematosus	4.09e-05	0.000154	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1RN—systemic lupus erythematosus	4.07e-05	0.000154	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—PPARG—systemic lupus erythematosus	4.06e-05	0.000153	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—CDKN1A—systemic lupus erythematosus	4.04e-05	0.000153	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—TLR4—systemic lupus erythematosus	4.03e-05	0.000152	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—IL6—systemic lupus erythematosus	3.99e-05	0.000151	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—IL6—systemic lupus erythematosus	3.97e-05	0.00015	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—IL6—systemic lupus erythematosus	3.95e-05	0.000149	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—IL6—systemic lupus erythematosus	3.95e-05	0.000149	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—IL6—systemic lupus erythematosus	3.95e-05	0.000149	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—IL6—systemic lupus erythematosus	3.95e-05	0.000149	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	3.93e-05	0.000149	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CRP—systemic lupus erythematosus	3.93e-05	0.000149	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—IL6—systemic lupus erythematosus	3.93e-05	0.000148	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—MMP9—systemic lupus erythematosus	3.92e-05	0.000148	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	3.92e-05	0.000148	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—IL6—systemic lupus erythematosus	3.92e-05	0.000148	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—IL6—systemic lupus erythematosus	3.88e-05	0.000147	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—IL6—systemic lupus erythematosus	3.86e-05	0.000146	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PTPRC—systemic lupus erythematosus	3.82e-05	0.000144	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TLR9—systemic lupus erythematosus	3.81e-05	0.000144	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1RN—systemic lupus erythematosus	3.81e-05	0.000144	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD40—systemic lupus erythematosus	3.8e-05	0.000144	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—PPARG—systemic lupus erythematosus	3.79e-05	0.000143	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	3.78e-05	0.000143	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—TLR4—systemic lupus erythematosus	3.77e-05	0.000142	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CTLA4—systemic lupus erythematosus	3.74e-05	0.000141	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HMGB1—systemic lupus erythematosus	3.74e-05	0.000141	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CD80—systemic lupus erythematosus	3.72e-05	0.000141	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—IL6—systemic lupus erythematosus	3.7e-05	0.00014	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—IL6—systemic lupus erythematosus	3.7e-05	0.00014	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—IL6—systemic lupus erythematosus	3.7e-05	0.00014	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—P2RY12—systemic lupus erythematosus	3.69e-05	0.000139	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IFNA1—systemic lupus erythematosus	3.68e-05	0.000139	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—MMP9—systemic lupus erythematosus	3.67e-05	0.000139	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	3.67e-05	0.000139	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—IL6—systemic lupus erythematosus	3.66e-05	0.000138	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—IL6—systemic lupus erythematosus	3.63e-05	0.000137	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—IL6—systemic lupus erythematosus	3.62e-05	0.000137	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—RASGRP1—systemic lupus erythematosus	3.58e-05	0.000135	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD79A—systemic lupus erythematosus	3.57e-05	0.000135	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TLR9—systemic lupus erythematosus	3.57e-05	0.000135	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TYK2—systemic lupus erythematosus	3.55e-05	0.000134	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD40—systemic lupus erythematosus	3.55e-05	0.000134	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—VEGFA—systemic lupus erythematosus	3.52e-05	0.000133	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CTLA4—systemic lupus erythematosus	3.5e-05	0.000132	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HMGB1—systemic lupus erythematosus	3.5e-05	0.000132	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	3.5e-05	0.000132	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	3.49e-05	0.000132	CbGpPWpGaD
Trametinib—MAP2K2—Disease—JUNB—systemic lupus erythematosus	3.48e-05	0.000132	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CD80—systemic lupus erythematosus	3.48e-05	0.000131	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PRL—systemic lupus erythematosus	3.47e-05	0.000131	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—P2RY12—systemic lupus erythematosus	3.45e-05	0.00013	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IFNA1—systemic lupus erythematosus	3.44e-05	0.00013	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CSK—systemic lupus erythematosus	3.4e-05	0.000128	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	3.38e-05	0.000128	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—RASGRP1—systemic lupus erythematosus	3.35e-05	0.000127	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD79A—systemic lupus erythematosus	3.34e-05	0.000126	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TYK2—systemic lupus erythematosus	3.33e-05	0.000126	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-DQA1—systemic lupus erythematosus	3.3e-05	0.000125	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—VEGFA—systemic lupus erythematosus	3.3e-05	0.000125	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	3.27e-05	0.000124	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	3.26e-05	0.000123	CbGpPWpGaD
Trametinib—MAP2K1—Disease—JUNB—systemic lupus erythematosus	3.26e-05	0.000123	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PRL—systemic lupus erythematosus	3.25e-05	0.000123	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PRL—systemic lupus erythematosus	3.21e-05	0.000121	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CSK—systemic lupus erythematosus	3.18e-05	0.00012	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	3.16e-05	0.00012	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—TYK2—systemic lupus erythematosus	3.14e-05	0.000119	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NCF2—systemic lupus erythematosus	3.11e-05	0.000117	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—LYN—systemic lupus erythematosus	3.09e-05	0.000117	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-DQA1—systemic lupus erythematosus	3.08e-05	0.000117	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-DQB1—systemic lupus erythematosus	3.08e-05	0.000116	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—JAK1—systemic lupus erythematosus	3.04e-05	0.000115	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.03e-05	0.000114	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PRL—systemic lupus erythematosus	3e-05	0.000113	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—TYK2—systemic lupus erythematosus	2.94e-05	0.000111	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL18—systemic lupus erythematosus	2.92e-05	0.00011	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD40LG—systemic lupus erythematosus	2.91e-05	0.00011	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NCF2—systemic lupus erythematosus	2.91e-05	0.00011	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LYN—systemic lupus erythematosus	2.89e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-DQB1—systemic lupus erythematosus	2.88e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCR5—systemic lupus erythematosus	2.88e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD8A—systemic lupus erythematosus	2.88e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—JAK1—systemic lupus erythematosus	2.84e-05	0.000108	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	2.84e-05	0.000107	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CD4—systemic lupus erythematosus	2.84e-05	0.000107	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SH2B3—systemic lupus erythematosus	2.83e-05	0.000107	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—C3—systemic lupus erythematosus	2.82e-05	0.000106	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—MMP9—systemic lupus erythematosus	2.8e-05	0.000106	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—JAK1—systemic lupus erythematosus	2.78e-05	0.000105	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL6—systemic lupus erythematosus	2.74e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL18—systemic lupus erythematosus	2.73e-05	0.000103	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD40LG—systemic lupus erythematosus	2.72e-05	0.000103	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.7e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCR5—systemic lupus erythematosus	2.7e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD8A—systemic lupus erythematosus	2.69e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—IL6—systemic lupus erythematosus	2.69e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CDKN1B—systemic lupus erythematosus	2.67e-05	0.000101	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	2.66e-05	0.0001	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CD4—systemic lupus erythematosus	2.66e-05	0.0001	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—EP300—systemic lupus erythematosus	2.65e-05	0.0001	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—C3—systemic lupus erythematosus	2.63e-05	9.96e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—MMP9—systemic lupus erythematosus	2.62e-05	9.9e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—JAK1—systemic lupus erythematosus	2.6e-05	9.82e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL2RA—systemic lupus erythematosus	2.59e-05	9.81e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—C3—systemic lupus erythematosus	2.57e-05	9.72e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—JAK1—systemic lupus erythematosus	2.57e-05	9.69e-05	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL6—systemic lupus erythematosus	2.56e-05	9.68e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—IL6—systemic lupus erythematosus	2.52e-05	9.52e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—VEGFA—systemic lupus erythematosus	2.51e-05	9.5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CDKN1B—systemic lupus erythematosus	2.5e-05	9.44e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.48e-05	9.39e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—EP300—systemic lupus erythematosus	2.48e-05	9.38e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—F2—systemic lupus erythematosus	2.47e-05	9.34e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CDKN1A—systemic lupus erythematosus	2.46e-05	9.31e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CRP—systemic lupus erythematosus	2.45e-05	9.25e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—JUNB—systemic lupus erythematosus	2.44e-05	9.21e-05	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—IL6—systemic lupus erythematosus	2.44e-05	9.21e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CCR5—systemic lupus erythematosus	2.43e-05	9.19e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL2RA—systemic lupus erythematosus	2.43e-05	9.17e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—C3—systemic lupus erythematosus	2.41e-05	9.1e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—JAK1—systemic lupus erythematosus	2.4e-05	9.07e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—VEGFA—systemic lupus erythematosus	2.35e-05	8.89e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TLR4—systemic lupus erythematosus	2.35e-05	8.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HLA-DRB1—systemic lupus erythematosus	2.34e-05	8.86e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—EP300—systemic lupus erythematosus	2.34e-05	8.86e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.32e-05	8.78e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.32e-05	8.75e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—F2—systemic lupus erythematosus	2.31e-05	8.74e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TGFB1—systemic lupus erythematosus	2.31e-05	8.72e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CDKN1A—systemic lupus erythematosus	2.3e-05	8.71e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CRP—systemic lupus erythematosus	2.29e-05	8.65e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—JUNB—systemic lupus erythematosus	2.28e-05	8.62e-05	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—IL6—systemic lupus erythematosus	2.28e-05	8.61e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CCR5—systemic lupus erythematosus	2.27e-05	8.59e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PRL—systemic lupus erythematosus	2.25e-05	8.49e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.2e-05	8.33e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TLR4—systemic lupus erythematosus	2.2e-05	8.3e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HLA-DRB1—systemic lupus erythematosus	2.19e-05	8.29e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—EP300—systemic lupus erythematosus	2.19e-05	8.29e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.17e-05	8.19e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD80—systemic lupus erythematosus	2.17e-05	8.18e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TGFB1—systemic lupus erythematosus	2.16e-05	8.16e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TNF—systemic lupus erythematosus	2.15e-05	8.14e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	2.15e-05	8.11e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PRL—systemic lupus erythematosus	2.1e-05	7.94e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.06e-05	7.79e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD80—systemic lupus erythematosus	2.03e-05	7.66e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—systemic lupus erythematosus	2.02e-05	7.62e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—TYK2—systemic lupus erythematosus	2e-05	7.56e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CD80—systemic lupus erythematosus	2e-05	7.56e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.87e-05	7.07e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CD80—systemic lupus erythematosus	1.87e-05	7.07e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TYK2—systemic lupus erythematosus	1.83e-05	6.91e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—JAK1—systemic lupus erythematosus	1.8e-05	6.79e-05	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—IL6—systemic lupus erythematosus	1.74e-05	6.57e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IFNG—systemic lupus erythematosus	1.71e-05	6.47e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TYK2—systemic lupus erythematosus	1.71e-05	6.46e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.71e-05	6.44e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCR5—systemic lupus erythematosus	1.7e-05	6.43e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TYK2—systemic lupus erythematosus	1.69e-05	6.38e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—JAK1—systemic lupus erythematosus	1.68e-05	6.35e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.68e-05	6.34e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL2—systemic lupus erythematosus	1.66e-05	6.29e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—C3—systemic lupus erythematosus	1.66e-05	6.29e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS3—systemic lupus erythematosus	1.66e-05	6.26e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CD4—systemic lupus erythematosus	1.65e-05	6.25e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—IL6—systemic lupus erythematosus	1.63e-05	6.15e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IFNG—systemic lupus erythematosus	1.6e-05	6.05e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCR5—systemic lupus erythematosus	1.59e-05	6.02e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TYK2—systemic lupus erythematosus	1.58e-05	5.97e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.57e-05	5.93e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL2—systemic lupus erythematosus	1.56e-05	5.89e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—C3—systemic lupus erythematosus	1.56e-05	5.88e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CDKN1B—systemic lupus erythematosus	1.55e-05	5.87e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS3—systemic lupus erythematosus	1.55e-05	5.86e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CD4—systemic lupus erythematosus	1.55e-05	5.85e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—systemic lupus erythematosus	1.54e-05	5.8e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.53e-05	5.8e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CD4—systemic lupus erythematosus	1.53e-05	5.77e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL2—systemic lupus erythematosus	1.52e-05	5.75e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTGS2—systemic lupus erythematosus	1.52e-05	5.73e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—F2—systemic lupus erythematosus	1.46e-05	5.52e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CDKN1B—systemic lupus erythematosus	1.45e-05	5.5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—systemic lupus erythematosus	1.44e-05	5.43e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CDKN1B—systemic lupus erythematosus	1.44e-05	5.42e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CDKN1A—systemic lupus erythematosus	1.43e-05	5.42e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CD4—systemic lupus erythematosus	1.43e-05	5.4e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL2—systemic lupus erythematosus	1.42e-05	5.38e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTGS2—systemic lupus erythematosus	1.42e-05	5.36e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CD80—systemic lupus erythematosus	1.4e-05	5.29e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—F2—systemic lupus erythematosus	1.37e-05	5.16e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—EP300—systemic lupus erythematosus	1.36e-05	5.16e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CDKN1B—systemic lupus erythematosus	1.34e-05	5.07e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CDKN1A—systemic lupus erythematosus	1.34e-05	5.07e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.34e-05	5.07e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CDKN1A—systemic lupus erythematosus	1.32e-05	5.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CD80—systemic lupus erythematosus	1.31e-05	4.95e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL2—systemic lupus erythematosus	1.3e-05	4.92e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—EP300—systemic lupus erythematosus	1.28e-05	4.83e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—EP300—systemic lupus erythematosus	1.26e-05	4.76e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CDKN1A—systemic lupus erythematosus	1.24e-05	4.68e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL2—systemic lupus erythematosus	1.22e-05	4.6e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	1.2e-05	4.55e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TYK2—systemic lupus erythematosus	1.18e-05	4.47e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—EP300—systemic lupus erythematosus	1.18e-05	4.46e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOS3—systemic lupus erythematosus	1.16e-05	4.38e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.15e-05	4.35e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.12e-05	4.22e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TYK2—systemic lupus erythematosus	1.11e-05	4.18e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TGFB1—systemic lupus erythematosus	1.1e-05	4.14e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOS3—systemic lupus erythematosus	1.09e-05	4.1e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TGFB1—systemic lupus erythematosus	1.02e-05	3.87e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.01e-05	3.8e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL2—systemic lupus erythematosus	9.84e-06	3.72e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—systemic lupus erythematosus	9.79e-06	3.7e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	9.4e-06	3.55e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MMP9—systemic lupus erythematosus	9.31e-06	3.52e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.27e-06	3.51e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL2—systemic lupus erythematosus	9.2e-06	3.48e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—systemic lupus erythematosus	9.16e-06	3.46e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—systemic lupus erythematosus	8.94e-06	3.38e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EP300—systemic lupus erythematosus	8.83e-06	3.34e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MMP9—systemic lupus erythematosus	8.71e-06	3.29e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	8.68e-06	3.28e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—systemic lupus erythematosus	8.37e-06	3.16e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.36e-06	3.16e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EP300—systemic lupus erythematosus	8.26e-06	3.12e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—systemic lupus erythematosus	8.26e-06	3.12e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—VEGFA—systemic lupus erythematosus	7.82e-06	2.96e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—systemic lupus erythematosus	7.72e-06	2.92e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.67e-06	2.9e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	7.59e-06	2.87e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.18e-06	2.71e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	6.83e-06	2.58e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	6.53e-06	2.47e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	6.46e-06	2.44e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	5.97e-06	2.26e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—systemic lupus erythematosus	5.78e-06	2.18e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—systemic lupus erythematosus	5.41e-06	2.04e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	4.97e-06	1.88e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	4.08e-06	1.54e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	3.67e-06	1.39e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	3.51e-06	1.33e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	3.21e-06	1.21e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2.67e-06	1.01e-05	CbGpPWpGaD
